===
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED
CAPITAL
02-Jul-2024 / 14:53 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Sartorius Stedim Biotech S.A. - 13781 Aubagne Cedex, France
DECLARATION RELATIVE TO
THE NUMBER OF SHARES AND VOTING RIGHTS
MAKING UP THE ISSUED CAPITAL
Article L 233-8-II of the Code of commerce
and article 223-6 of the general regulations of the AMF
Designation of issuer
SARTORIUS STEDIM BIOTECH SA
CS 91051
Z. I. Les Paluds
Avenue de Jouques
13781 Aubagne Cedex
Date of Total number of shares making up Total number of theoretical voting rights Total number of net
information the issued capital including treasury shares voting rights
June 30, 2024 97,330,405 165,575,822 165,528,510
===
-----------------------------------------------------------------------------------------------------------------------
Regulatory filing PDF file File: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
===
Language: English
Company: Sartorius Stedim Biotech SA
Avenue de Jouques
13781 Aubagne
France
Phone: +33 44 284 5600
E-mail: sartorius.presse@sartorius.com
Internet: www.sartorius-stedim.com
ISIN: FR0013154002
Euronext DIM
Ticker:
AMF Category: Total number of voting rights and share capital / Information on the total number of voting rights and
the number of shares making up the share capital
EQS News ID: 1938119
End of Announcement EQS News Service
===
1938119 02-Jul-2024 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1938119&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face
END) Dow Jones Newswires
July 02, 2024 08:54 ET (12:54 GMT)